Drug Type Monoclonal antibody |
Synonyms anti-DKK2 humanized mAb (solid cancer) |
Mechanism DKK2 inhibitors(Dickkopf-related protein 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |